| Year |
Citation |
Score |
| 2017 |
Blakeley JO, Bakker A, Barker A, Clapp W, Ferner R, Fisher MJ, Giovannini M, Gutmann DH, Karajannis MA, Kissil JL, Legius E, Lloyd AC, Packer RJ, Ramesh V, Riccardi VM, et al. The path forward: 2015 International Children's Tumor Foundation conference on neurofibromatosis type 1, type 2, and schwannomatosis. American Journal of Medical Genetics. Part A. PMID 28436162 DOI: 10.1002/Ajmg.A.38239 |
0.381 |
|
| 2013 |
Nalepa G, Barnholtz-Sloan J, Enzor R, Dey D, He Y, Gehlhausen JR, Lehmann AS, Park SJ, Yang Y, Yang X, Chen S, Guan X, Chen Y, Renbarger J, Yang FC, ... ... Clapp W, et al. The tumor suppressor CDKN3 controls mitosis. The Journal of Cell Biology. 201: 997-1012. PMID 23775190 DOI: 10.1083/Jcb.201205125 |
0.386 |
|
| 2006 |
Yu X, Milas J, Watanabe N, Rao N, Murthy S, Potter OL, Wenning MJ, Clapp WD, Hock JM. Neurofibromatosis type 1 gene haploinsufficiency reduces AP-1 gene expression without abrogating the anabolic effect of parathyroid hormone Calcified Tissue International. 78: 162-170. PMID 16525748 DOI: 10.1007/s00223-005-0201-x |
0.331 |
|
| 2004 |
Yang G, Khalaf W, Clapp WD, Hiebert SW. Neurofibromatosis Type 1 (NF1), a Tumor Suppressor Gene, Is Synergistically Activated by RUNX1, C/EBPαa and ETS2 and Specifically Repressed by the T(8;21) Fusion Protein in Acute Myeloid Leukemia. Blood. 104: 2551-2551. DOI: 10.1182/Blood.V104.11.2551.2551 |
0.412 |
|
| Show low-probability matches. |